Menú

Filtros

  • Resultados obtenidos en

Metrix COVID-19 Test Kit Non-Prescription Home Use For 25/Bx

Metrix MTRX-C19-25PK COVID-19 Test Kit

Medical Diagnostic & Emergency / Laboratory - Medical / 1460426 | Sekisui Diagnostics LLC - MTRX-C19-25PK
  2. /
  3. Insumos y equipos pequeños
  4. /
  5. Búsqueda de insumos
  6. /
  7. Categoría: Medical Diagnostic & Emergency
  8. /
  9. Metrix COVID-19 Test Kit Non-Prescription Home Use For 25/Bx
Metrix COVID-19 Test Kit Non-Prescription Home Use For 25/Bx
Comparar
  • Categoría:
    Medical Diagnostic & Emergency / Laboratory - Medical / Molecular Testing
  • UNSPSC:
    41116100

  • Metrix COVID-19 Test Kit Non-Prescription Home Use For 25/Bx 1460426 | Sekisui Diagnostics LLC - MTRX-C19-25PK

  • Descripción:
    Metrix COVID-19 Test Kit Non-Prescription Home Use For 25/Box
  • Categoría:
    Medical Diagnostic & Emergency / Laboratory - Medical
  • UNSPSC:
    41116100
  • Opciones de empaque (1)

Descripción del producto Resumen de las funciones del producto

Features & Benefits:

    • • This product has not been FDA cleared or approved, but has been authorized for non-prescription use by FDA under an EUA
    • • This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens
    • • The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner

Especificaciones Especificaciones y medidas de los productos

  • Brand
    Metrix
  • CLIA Classification
    Non-Prescription Home Use
  • Item
    Test Kit
  • Item Type
    COVID-19

Description du catalogue Tal como se ve en nuestro catálogo impreso

The Metrix Molecular Platform is a highly sensitive and proven isothermal amplification technology designed to eliminate cost barriers associated with molecular testing, empowering health-care providers to offer high-quality testing anywhere and everywhere. Can accurately detect and differentiate between SARS-CoV-2, influenza A, and influenza B at the point of care.

Continuar comprando
Henry Schein Henry Schein